iShares Genomics Immunology and Healthcare ETF IDNA

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IDNA

Will IDNA outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Genomics Immnlgy & Hlthcr ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IDNA

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings52.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

14.9252M
Healthcare

Genmab AS

5.9421M
Healthcare

Twist Bioscience Corp

4.8617M
Healthcare

Bayer AG

4.1315M
Healthcare

Regeneron Pharmaceuticals Inc

3.9614M
Healthcare

Takeda Pharmaceutical Co Ltd

3.7513M
Healthcare

Exelixis Inc

3.6713M
Healthcare

Revolution Medicines Inc Ordinary Shares

3.5913M
Healthcare

Vertex Pharmaceuticals Inc

3.4112M
Healthcare

Merck & Co Inc

3.3812M
Healthcare

Sponsor Center